Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion
OrthoSpineNews
JUNE 23, 2025
ASPIRE pivotal Level-1 PMA IDE study evaluated PearlMatrix vs. local autograft in single-level TLIF procedures: – Demonstrated statistically superior fusion speed; – Achieved over twice as many patients fused at six months; – Included ~60% high-risk patients WESTMINSTER, Colo., 3 The ASPIRE trial included 33 U.S.
Let's personalize your content